Revenue

A $41.25M deal for a new cottage-style community in Monroe, NC, highlights a growing housing trend and an investor's bet on 'affordable' suburban living.

Recognized as a Major Player by IDC, South Korea's SK shieldus leverages its AI platform to expand globally and serve businesses of all sizes.

MGM Resorts moved its earnings date up, and now we know why. The gaming giant beat Wall Street estimates with powerful results from BetMGM and Macau.

Former Senator Joe Manchin and pharma exec Heather Manchin join BlinkRx, bringing political and industry muscle to the fight for affordable medicine.

Hawk Ridge Systems expands its portfolio with Stratasys' production-grade 3D printing, aiming to dominate the end-to-end additive manufacturing market.

Investors brace for South Bow's year-end results, seeking answers on pipeline repairs, new project cash flows, and its strategy in a shifting energy market.

A small Okanagan town's generosity during wildfires and beyond earned it a national title and a $100,000 grant to further bolster its community spirit.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

With its Q4 results announcement imminent, specialty insurer Trisura is under scrutiny to prove it can sustain growth amid market pressures and investor concerns.

Facing a stock slump and operational woes, Clorox leaders must deliver a convincing turnaround plan at the upcoming CAGNY investor conference.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

Amid financial headwinds, specialty chemicals firm Orion S.A. will pitch its strategic pivot to the high-growth EV and sustainable materials markets.

Stablecoin giant Tether's $150M investment in Gold.com signals a new era, merging physical gold with blockchain to redefine asset ownership.

Early trial data for ABX1100 reveals a novel approach to reducing muscle damage in Pompe disease, offering hope for less burdensome treatment.

Viking Therapeutics' upcoming earnings call is about more than just financials. Investors are focused on key pipeline updates for its obesity and MASH drugs.

The homebuilder's 10% dividend hike reflects strong financials and hints at a broader recovery for the U.S. housing sector. What does this mean for investors?

GameAbove's new invitational isn't just another tournament; it's a strategic play to elevate women's golf, backed by millions in investment.

Following a massive acquisition, VSE Corp. prepares to outline its future growth and market strategy at two major February investor conferences.

With the appointment of Kash Mohammed as President, intelliSPEC signals a major push to unify its platform and lead the AI revolution in industrial asset management.

Tampa Bay Wave's 2026 accelerator welcomes 15 elite startups, signaling the region's growing dominance in the global cybersecurity landscape.